Food, Medicine and Health Care Administration and Control Authority (FMHACA)

Food, Medicine and Health Care Administration and Control Authority (FMHACA)
Name	Food, Medicine and Health Care Administration and Control Authority
Formation	2000s
Headquarters	Addis Ababa
Region served	Ethiopia

Food, Medicine and Health Care Administration and Control Authority (FMHACA) is Ethiopia's national regulatory body charged with oversight of pharmaceuticals, food safety, and medical devices within the Federal Democratic Republic of Ethiopia. It operated in a landscape shaped by interactions with international partners such as the World Health Organization, United Nations Children's Fund, and bilateral agencies including the United States Agency for International Development and European Union. FMHACA's work intersected with national actors like the Ministry of Health (Ethiopia), regional health bureaus, and academic institutions such as Addis Ababa University.

History

FMHACA was created in the context of regulatory reform following policy discussions influenced by the World Health Assembly and technical guidance from World Health Organization experts, modeled partly after agencies like the United States Food and Drug Administration and the European Medicines Agency. Early collaboration included projects with United States Agency for International Development and Centers for Disease Control and Prevention to bolster capacity for drug registration and pharmacovigilance. During its tenure FMHACA engaged with initiatives led by Global Fund to Fight AIDS, Tuberculosis and Malaria, Gavi, the Vaccine Alliance, and Medicines Transparency Alliance to improve access to essential medicines and vaccines. Periodic legal reforms touched on elements of the Ethiopian Food and Drug Administration Proclamation and influenced relationships with regulatory actors such as the African Union and its Africa Centres for Disease Control and Prevention.

Mandate and Functions

FMHACA's mandate covered registration and licensing tasks similar to the European Commission directives on medicinal products and the World Health Organization Model List of Essential Medicines. Its functional scope included product evaluation akin to procedures at the Therapeutic Goods Administration (Australia), quality assurance comparable to United States Pharmacopeia standards, and surveillance activities influenced by Pharmacovigilance Risk Assessment Committee. It coordinated with international procurement bodies like the Global Fund to Fight AIDS, Tuberculosis and Malaria and with national policy implementers such as the Federal Ministry of Health (Ethiopia) and regional health bureaus in Amhara Region, Oromia Region, and Tigray Region.

Organizational Structure

FMHACA's internal organization mirrored models from agencies such as the Medicines and Healthcare products Regulatory Agency and featured divisions for medicines, food, and medical devices. Leadership reported to ministries analogous to reporting channels used by the Ministry of Health (United Kingdom) and engaged technical advisory groups similar to those at the Pan American Health Organization. The authority liaised with academic partners including Jimma University and Haramaya University for research and training, and collaborated with international standard-setters such as the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use and International Organization for Standardization.

Regulation and Enforcement Activities

Regulatory actions by FMHACA encompassed product registration, market authorization, inspection and licensing of establishments — functions comparable to enforcement undertaken by the United States Food and Drug Administration and Health Canada. FMHACA implemented quality control testing in laboratories that sought accreditation similar to standards from the International Laboratory Accreditation Cooperation and participated in drug safety monitoring paralleling systems like the European Medicines Agency pharmacovigilance framework. Enforcement interactions involved law enforcement counterparts such as the Ethiopian Federal Police when addressing counterfeit medicines and illicit trade, and coordination with customs authorities at points of entry like Addis Ababa Bole International Airport.

Notable Programs and Initiatives

FMHACA launched programs to strengthen pharmacovigilance inspired by the WHO Programme for International Drug Monitoring and implemented vaccine lot release practices aligning with Gavi, the Vaccine Alliance requirements. Capacity-building collaborations included training supported by United States Agency for International Development, laboratory upgrades with technical assistance from World Health Organization, and participation in regional harmonization efforts under the African Medicines Regulatory Harmonization initiative. The authority also promoted essential medicine lists in coordination with World Health Organization Model List of Essential Medicines adoption processes and engaged in public awareness campaigns similar to projects by UNICEF.

Challenges and Reforms

FMHACA faced challenges comparable to other emerging regulatory authorities, including limited laboratory infrastructure, shortages of trained personnel, and pressures from informal markets and cross-border trade with neighbors such as Kenya and Sudan. Reforms drew on lessons from regulatory transitions like those experienced by South Africa and Nigeria and included efforts toward harmonization with African Medicines Regulatory Harmonization and alignment with International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use guidelines. Stakeholders in reform processes included multilaterals such as World Health Organization, donors like European Union, and domestic institutions including the Ministry of Health (Ethiopia) and Parliament of Ethiopia.

Category:Regulatory authorities Category:Health in Ethiopia